Filing status
- Accounts due
- 31 July 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 2 November 2027
- Last conf. stmt
- 19 October 2026
Causeway Therapeutics Limited
- Incorporated
- 20 October 2015 (11 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Earl Alexander PickettGregor CaldowNeil Gibson
- Accounts type
- Small
- Region
- Scotland
- Address
- Imaging Centre Of ExcellenceQueen Elizabeth University HospitalGlasgowG51 4TF
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 7 active
Officer details are public data from the Companies House register.
Pickett, Earl Alexander
Director · Appointed 3 February 2023
American
Born August 1987 (39)
Caldow, Gregor
Director · Appointed 1 July 2022
British
Born September 1976 (50)
Millar, Neal Lindsay
Secretary · Appointed 4 December 2019
Gibson, Neil, Dr
Director · Appointed 12 September 2017
American
Born April 1956 (70)
Jones, Christopher Michael
Director · Appointed 1 September 2017
American
Born October 1966 (60)
Doogan, Declan, Dr
Director · Appointed 1 September 2017
American
Born March 1952 (74)
Gilchrist, Derek, Dr
Director · Appointed 11 November 2015
British
Born April 1970 (56)
Officer history (2 former)
3 February 2023
Appointed Pickett, Earl Alexander as Director
1 July 2022
Appointed Caldow, Gregor as Director
30 June 2022
30 September 2021
30 September 2021
4 December 2019
Appointed Millar, Neal Lindsay as Secretary
12 September 2017
Appointed Gibson, Neil, Dr as Director
1 September 2017
Appointed Jones, Christopher Michael as Director
1 September 2017
Appointed Doogan, Declan, Dr as Director
11 November 2015
Appointed Gilchrist, Derek, Dr as Director
20 October 2015
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
7 February 2019
Ceased Scottish Enterprise — Owns 25–50% of shares
19 June 2018
Ceased G U Holdings Limited — Owns 25–50% of shares
Financials
Balance sheet as at 31 October 2025 · small accounts
- Cash
- £1,366,835
- Employees
- 7
- Current Ratio
- 1.3x
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £0 | £39,429 | £1,031 | ||||
| Current Assets | £1,501,694 | £3,920,762 | £6,172,671 | £377,842 | £1,472,678 | £762,840 | £443,978 |
| Debtors | £134,859 | £87,294 | £207,272 | £118,526 | £285,639 | £225,892 | £237,649 |
| Cash | £1,366,835 | £3,833,468 | £5,965,399 | £259,316 | £1,187,039 | £536,948 | £206,329 |
| Creditors (< 1 year) | £1,113,321 | £302,474 | £195,468 | £2,393,557 | £94,030 | £248,378 | £139,754 |
| Creditors (> 1 year) | £0 | £1,595,000 | £220,000 | ||||
| Net Current Assets | £388,373 | £3,618,288 | £5,977,203 | (£2,015,715) | £1,378,648 | £514,462 | £304,224 |
| Net Assets | (£2,015,715) | (£216,352) | £333,891 | ||||
| Shareholder Funds | £388,373 | £3,618,288 | £5,977,203 | (£2,015,715) | (£216,352) | £333,891 | £305,255 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 November 2026 | Notification of a person with significant control | |||
| 6 November 2026 | Confirmation statement with updates | 19 October 2026 | ||
| 6 November 2026 | Withdrawal of a person with significant control statement | |||
| 6 November 2026 | Memorandum and Articles of Association | |||
| 6 November 2026 | Resolutions |
Some other companies at this address
Other companies in this industry
Edinburgh
Cambridge
Cambridge
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →